Molecular profiling of neuroendocrine malignancies to identify prognostic and therapeutic markers: a Fox Chase Cancer Center Pilot Study

BACKGROUND: The rarity of neuroendocrine malignancies limits the ability to develop new therapies and thus a better understanding of the underlying biology is critical. METHODS: Through a prospective, IRB-approved protocol, patients with neuroendocrine malignancies underwent next-generation sequenci...

Descripción completa

Detalles Bibliográficos
Autores principales: Vijayvergia, Namrata, Boland, Patrick M, Handorf, Elizabeth, Gustafson, Karen S, Gong, Yulan, Cooper, Harry S, Sheriff, Fathima, Astsaturov, Igor, Cohen, Steven J, Engstrom, Paul F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Molecular Diagnostics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4997552/
https://www.ncbi.nlm.nih.gov/pubmed/27482646
http://dx.doi.org/10.1038/bjc.2016.229

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4997552/
https://www.ncbi.nlm.nih.gov/pubmed/27482646
http://dx.doi.org/10.1038/bjc.2016.229

Ejemplares similares